Shopping Cart
- Remove All
- Your shopping cart is currently empty
SDU-071 is an orally active BRD4-p53 inhibitor, inhibiting the proliferation of MDA-MB-231 cells, blocking the interaction between BRD4 and the tumor suppressor p53, downregulating the expression of BRD4-targeted genes, thereby inhibiting cell proliferation, migration, and invasion, and inducing cell cycle arrest and apoptosis. SDU-071 is used for research on triple-negative breast cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $68 | In Stock | |
5 mg | $166 | In Stock | |
10 mg | $275 | In Stock | |
25 mg | $595 | In Stock | |
50 mg | $862 | In Stock | |
100 mg | $1,160 | In Stock | |
500 mg | $2,320 | In Stock |
Description | SDU-071 is an orally active BRD4-p53 inhibitor, inhibiting the proliferation of MDA-MB-231 cells, blocking the interaction between BRD4 and the tumor suppressor p53, downregulating the expression of BRD4-targeted genes, thereby inhibiting cell proliferation, migration, and invasion, and inducing cell cycle arrest and apoptosis. SDU-071 is used for research on triple-negative breast cancer. |
In vitro | SDU-071 is a novel BRD4-p53 inhibitor. SDU-071 (10 μM, 24 h) inhibits the interaction of BRD4 with p53 tumor suppressor. [1] |
In vivo | In an orthotopic mouse xenograft breast tumor model, SDU-071 (250 mg/kg, gavage, Once a day for 21 days) showed good antitumor activity. [1] |
Alias | SDU071 |
Molecular Weight | 435.52 |
Formula | C28H25N3O2 |
Smiles | COC(C=C1)=CC=C1NCC(C=C2NC3=CC=C(OC)C=C3)=NC4=C2C=CC5=C4C=CC=C5 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (183.69 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.